Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.

Amiot, Aurelien;Bourrier, Anne;Gornet, Jean-Marc;Dewit, Olivier;GETAID-INFOPRO study group;et.al.
(2023) Infection Prevention in Practice — Vol. 5, n° 1, p. 100267 [1-9] (2023)

Files

2023_Amiot_Infect_Prev_Pract.pdf
  • Open Access
  • Adobe PDF
  • 581.93 KB
  • https://creativecommons.org/licenses/by/4.0/
Download

Details

Authors
  • Amiot, Aurelien
    Author
  • Bourrier, Anne
    Author
  • Gornet, Jean-Marc
    Author
  • Dewit, OlivierUCLouvain
    Author
  • GETAID-INFOPRO study group
    Collaborator
Show more
Abstract
BACKGROUND: Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. AIM: To assess the risk of COVID-19 in healthcare workers with IBD. METHODS: A case control study enrolled 326 healthcare workers with IBD from 17 GETAID centres and matched non-healthcare workers with IBD controls (1:1) for gender, age, disease subtype and year of diagnosis. The study period was year 2020 during the COVID-19 outbreak. RESULTS: In total, 59 COVID-19 were recorded among cases (n = 32) and controls (n = 27), including 2 severe COVID-19 (requiring hospitalization, mechanic ventilation) but no death. No difference was observed between healthcare workers and controls regarding the overall incidence rates of COVID-19 4.9 ± 2.2 vs. 3.8 ± 1.9 per 100 patient-semesters, P = 0.34) and the overall incidence rates of severe COVID-19 (0.6 ± 7.8 vs. 0.3 ± 5.5 per 100 patient-semesters, P = 0.42). In multivariate analysis in the entire study population, COVID-19 was associated with patients with body mass index > 30 kg/m2 (HR = 2.48, 95%CI [1.13-5.44], P = 0.02). CONCLUSION: Healthcare workers with IBD do not have an increased risk of COVID-19 compared with other patients with IBD.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Amiot, A., Bourrier, A., Gornet, J.-M., Dewit, O., Nancey, S., Altwegg, R., Abitbol, V., Laharie, D., Reenaers, C., Gagnière, C., Buisson, A., Nachury, M., Viennot, S., Vuitton, L., Stefanescu, C., Marteau, P., Bouguen, G., & Seksik, P. (2023). Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study. Infection Prevention in Practice, 5(1), 100267 [1-9]. https://doi.org/10.1016/j.infpip.2022.100267 (Original work published 2023)